Roth MKM Initiates Coverage On Zimmer Biomet Holdings with Neutral Rating, Announces Price Target of $120
Portfolio Pulse from Benzinga Newsdesk
Roth MKM analyst Jason Wittes has initiated coverage on Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral rating and a price target of $120.
October 20, 2023 | 9:39 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Zimmer Biomet Holdings has been given a Neutral rating and a price target of $120 by Roth MKM.
The Neutral rating indicates that the analyst believes the stock will perform in line with the market average. This could mean that the stock's price will not change significantly in the short term. The price target of $120 provides a reference point for investors, but it does not necessarily indicate a strong upward or downward movement.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100